Level of Free Fat Acid Could Be Decreased in Obese Subjects after 6 Months' Treatment with Sibutramine

高鑫,孙璇,赵耐青,潘柏申,江孙芳,余丹菁,陆志强

DOI: https://doi.org/10.3969/j.issn.1672-8467.2002.04.002

2002-01-01

Abstract:Purpose To evaluate the effect of lose weight treated by sibutramine on free fatty acid(FFA) levels,and accordingly the relationship between changes of FFA and those of serum glucose level and lipid profiles,insulin sensitivi-ty and β cell function. Methods Forty-two obese patients(BMI≥24 kg/m 2,with or without impairment of glucose metabolism) were randomized in this double-blind,placebo-controlled study.Each patient received sibutramine or placebo for 6 months.All the participants were instructed to consume a low-calorie diet.The primary outcome measures were changes in weight and serum FFA levels.Secondary outcome measures were changes in anthropometrical parameters(BMI and WHR),serum glucose,lipid levels and the HOMA?IR. Results After 6 months of treatment,weight loss of sibutramine-treated objects was greater than that of placebo-treated objects(P=0.000 6).The declination of fasting serum FFA levels(P=0.002 5) in sibutramine group was also greater than that in placebo group(P=0.017 1),but there was no difference between two groups(P=0.764 1).The declination of FFA area in sibutramine group was greater than that in placebo group was(P=0.004 5),and there was still no difference between the subjects receiving sibutramine or placebo(P=0.907 1).Compared to the baseline,fasting glucose,lipid profile,insulin,HOMA?IR and proinsulin/insulin ratio between two groups declined to different extent. Conclusions After the antiobesity therapy,fasting FFA levels and FFA area were decreased depending on the extent of weight loss in both sibutramine group and placebo group.As weight loss and reduction of FFA,insulin sensitivity(the reduction of HOMA?IR) and β cell function(the reduction of proinsulin/insulin ratio) were improved in both groups.